Deuterated S- bupropion (DeuteRx)

N/A

Report date: 2026/04/23 20:00:25
NME

Base Information

Drug NameDeuterated S- bupropion (DeuteRx)
Drug Alias Named-S-bupropiondeuterium bupropiondeuterium-stabilized S-bupropionNTY-184DRX-184
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionDopamine reuptake inhibitors
TargetsDopamine transporter
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDeuterx
China Registration ClassN/A

Develop Information

Active CompaniesDeuterxAxsome Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A